DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Goldberg SB, Gettinger SN, Mahajan A. et al.
Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial.
Lancet Oncol 2016;
17: 976-983
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.